Patent details
EP3828265 Title: IMPROVED T CELL COMPOSITIONS
Basic Information
- Publication number:
- EP3828265
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP202055117
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- IMPROVED T CELL COMPOSITIONS
- French Title of Invention:
- COMPOSITIONS DE LYMPHOCYTES T AMÉLIORÉES
- German Title of Invention:
- VERBESSERTE T-ZELLENZUSAMMENSETZUNGEN
- SPC Number:
Dates
- Filing date:
- 05/06/2015
- Grant date:
- 07/05/2025
- EP Publication Date:
- 02/06/2021
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 07/05/2025
- EP B1 Publication Date:
- 07/05/2025
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 05/06/2035
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 30/04/2025
- Name:
- 2seventy bio, Inc.
- Address:
- 60 Binney Street, Cambridge, MA 02142, United States (US)
Inventor
- Name:
- FRIEDMAN, Kevin
- Address:
- United States (US)
Priority
- Priority Number:
- 201462008957 P
- Priority Date:
- 06/06/2014
- Priority Country:
- United States (US)
Classification
- IPC classification:
- C12N 5/0783; A61P 1/18; A61P 11/00; A61P 13/10; A61P 15/00; A61P 17/00; A61P 25/00; A61P 35/00; A61P 35/02; A61K 39/00;
Publication
European Patent Bulletin
- Issue number:
- 202519
- Publication date:
- 07/05/2025
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
- 07/07/2025
- Annual Fee Number:
- 11
- Annual Fee Amount:
- 148 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|